Home › Calculator › AGYTF Dividend Calculator 2026
AGYTF Dividend DRIP Calculator 2026
1333.33% YieldHealthcareAllergy Therapeutics plc · OTC
Price: $0.15 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When AGYTF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your AGYTF snowball 📈
$10,000 in AGYTF → $6.727888724040572e+22M in 10 years · $5,606,163,329,034,777,000,000,000,000.00/month
About Allergy Therapeutics plc (AGYTF) — Dividend Analysis 2026
Allergy Therapeutics plc is a biotechnology firm dedicated to the research, development, and commercialization of innovative treatments for allergic conditions. The company offers a variety of allergen-specific immunotherapies, available as both injectable solutions and sublingual (under-the-tongue) formulations. Their product line includes prescription medications specifically designed to address pollen-related allergies, such as those caused by grasses, weeds, and trees, along with various diagnostic tools. Key products in their portfolio feature names like Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Pollinex, VLP Peanut, and Penicillin diagnostics. Furthermore, Allergy Therapeutics is actively developing new allergy vaccines targeting a range of allergens, including trees, grass, house dust mites, animal dander, and peanuts. The company operates extensively across Central Europe, Southern Europe, the United Kingdom, and extends its market presence internationally. Established in 2004, Allergy Therapeutics plc is based in Worthing, United Kingdom.
Compare AGYTF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full AGYTF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AGYTF position with:
🌍 AGYTF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold AGYTF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1333.33% | 1330.53% | $133,333 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1133.33% | 1130.53% | $113,333 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1066.66% | 1063.86% | $106,666 / yr |
| 🇬🇧 UK ISA | 0% | 1333.33% | 1330.53% | $133,333 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1216.66% | 1213.86% | $121,666 / yr |
| 🇨🇦 TFSA | 0% | 1333.33% | 1330.53% | $133,333 / yr |
| 🇨🇦 CA Taxable | 25% | 1000.00% | 997.20% | $100,000 / yr |
| 🇦🇺 Super (pension) | 15% | 1133.33% | 1130.53% | $113,333 / yr |
| 🇦🇺 AU Taxable | 30% | 933.33% | 930.53% | $93,333 / yr |
| 🇩🇪 DE Taxable | 26.375% | 981.66% | 978.86% | $98,166 / yr |
| 🇫🇷 FR Taxable | 30% | 933.33% | 930.53% | $93,333 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 AGYTF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 AGYTF Dividend Payment Schedule
AGYTF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 AGYTF vs Healthcare Benchmarks
How AGYTF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AGYTF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ AGYTF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AGYTF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Allergy Therapeutics plc (AGYTF) is currently trading at $0.15, 71% below its 52-week high. The current dividend yield is 1333.33% based on an annual payout of $2.00 per share.
AGYTF (Allergy Therapeutics plc) — 1333.33% Dividend Yield Analysis
Allergy Therapeutics plc (AGYTF) is a healthcare stock currently trading at $0.15 with a dividend yield of 1333.33%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (1333.33%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.